Patents Assigned to Vianova Labs, Inc.
  • Patent number: 8293726
    Abstract: The present invention relates to a novel compound (e.g., 24-ethyl-cholestane-3?,5?,6?-triol), its production, its use, and to methods of treating neoplasms and other tumors as well as other diseases including hypercholesterolemia, autoimmune diseases, viral diseases (e.g., hepatitis B, hepatitis C, or HIV), and diabetes.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: October 23, 2012
    Assignee: Vianova Labs, Inc.
    Inventor: Nabil Francois Habib